Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model

FEMS Microbiology Letters

Volumn 315, Issue 2, 2011, Pages 87-93

  Khodavandi, Alireza ^a   Alizadeh, Fahimeh ^b   Harmal, Nabil S ^a   Sidik, Shiran M ^a   Othman, Fauziah ^a   Sekawi, Zamberi ^a   Jahromi, Mohammad Ali Farboodniay ^c   Ng, Kee Peng ^d   Chong, Pei Pei ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Allicin; Fluconazole; In vitro; In vivo

Indexed keywords

ALLICIN; FLUCONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; CANDIDA ALBICANS; CANDIDIASIS; CELL SURFACE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LETTER; LYSIS; MINIMUM INHIBITORY CONCENTRATION; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURVIVAL TIME;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; DISEASE MODELS, ANIMAL; FEMALE; FLUCONAZOLE; HUMANS; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, SCANNING; SULFINIC ACIDS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANIMALIA; CANDIDA ALBICANS; MUS;

EID: 78651416206     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2010.02170.x     Document Type: Letter

References (23)

1. Aala F, Yusuf UM, Khodavandi A & Jamal F (2010) In vitro antifungal activity of allicin alone and in combination with two medications against six dermatophytic fungi. Afr J Microbiol Res 4: 380-385.
2. Al-Mohsen I & Hughes WT (1998) Systemic antifungal therapy: past, present and future. Ann Saudi Med 18: 28-38.
3. An M, Shen H, Cao Y, Zhang J, Cai Y, Wang R & Jiang Y (2009) Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. Int J Antimicrob Ag 33: 258-263.
4. Ankri S & Mirelman D (1999) Antimicrobial properties of allicin from garlic. Microbes Infect 1: 125-129.
5. Ashman RB & Papadimitriou JM (1988) Murine candidiasis: strain dependence of host responses after immunization. Immunol Cell Biol 66: 231-237.
6. Chowta MN, Adhikari P, Rajeev A & Shenoy AK (2007) Study of risk factors and prevalence of invasive candidiasis in tertiary care hospital. Indian J Crit Care Med 11: 67-73.
7. Davis LE, Shen JK & Cai Y (1990) Antifungal activity in human cerebrospinal fluid and plasma after intravenous administration of Allium sativum. Antimicrob Agents Ch 34: 651-653.
8. Davis SR, Perrie R & Apitz-Castro R (2003) The in vitro susceptibility of Scedosporium prolificans to ajoene, allitridium and a raw extract of garlic (Allium sativum). J Antimicrob Chemoth 51: 593-597.
9. Guo N, Wu X, Yu L, Liu J, Meng R, Jin J, Lu H, Wang X, Yan S & Deng X (2010) In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods. FEMS Immunol Med Microbiol 58: 193-201.
10. Khodavandi A, Alizadeh F, Aala F, Sekawi Z & Chong PP (2010) In vitro investigation of antifungal activity of allicin alone and in combination with azoles against Candida species. Mycopathologia 169: 287-295.
11. Ledezma E, Maniscalchi MT & Espinoza DL (2008) Synergy between ajoene and ketoconazole in isolates of Microsporum canis. Rev Iberoam Micol 25: 157-162.
12. Lee BM & Park KK (2003) Beneficial and adverse effects of chemopreventive agents. Mutat Res 523-524: 265-278.
13. Lemar KM, Turner MP & Lloyd D (2002) Garlic (Allium sativum) as an anti-Candida agent: a comparison of the efficacy of fresh garlic and freeze-dried extracts. J Appl Microbiol 93: 398-405.
14. Lemar KM, Passa O, Aon MA, Cortassa S, Müller CT, Plummer S, O'Rourke B & Lloyd D (2005) Allyl alcohol and garlic (Allium sativum) extract produce oxidative stress in Candida albicans. Microbiology 151: 3257-3265.
15. Looi CY, D' Silva EC, Seow HF, Rosli R, Ng KP & Chong PP (2005) Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients. FEMS Microbiol Lett 249: 283-289.
16. Low CF, Chong PP, Yong PVC, Lim CSY, Ahmad Z & Othman F (2008) Inhibition of hyphae formation and SIR2 expression in Candida albicans treated with fresh Allium sativum (garlic) extract. J Appl Microbiol 105: 2169-2177.
17. Miron T, Bercovici T, Rabinkov A, Wilchek M & Mirelman D (2004) [3H]Allicin: preparation and applications. Anal Biochem 331: 364-369.
18. Odds FC, Brown AJP & Gow NAR (2003) Antifungal agents: mechanisms of action. Trends Microbiol 11: 272-279.
19. Pereira-Cenci T, Del Bel Cury AA, Crielaard W & Ten Cate JM (2008) Development of Candida-associated denture stomatitis: new insights. J Appl Oral Sci 16: 86-94.
20. Rabinkov A, Miron T, Konstantinovski L, Wilchek M, Mirelman D & Weiner L (1998) The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim Biophys Acta 1379: 233-244.
21. Rex JH, Nelson PW, Paetznick VL, Lozano-Chiu M, Espinel-Ingroff A & Anaissie EJ (1998) Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob Agents Ch 42: 129-134.
22. Shadkchan Y, Shemesh E, Mirelman D, Miron T, Rabinkov A, Wilchek M & Osherov N (2004) Efficacy of allicin, the reactive molecule of garlic, in inhibiting Aspergillus spp. in vitro, and in a murine model of disseminated aspergillosis. J Antimicrob Chemoth 53: 832-836.
23. Yamada Y & Azuma K (1977) Evaluation of the in vitro antifungal activity of allicin. Antimicrob Agents Ch 11: 743-749.